8BWW

Targeting Toll-like receptor-driven systemic inflammation by engineering an innate structural fold into drugs

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-1H TOCSY	1.6 mM sHVF18, 50 % v/v TFE, 10 % v/v D2O, 200 uM DSS, 0.02 % v/v sodium azide	trifluoroethanol/water	0	4.5	1 atm	298	Bruker AVANCE III HD 700
2	2D 1H-1H TOCSY	1.6 mM sHVF18, 50 % v/v TFE, 10 % v/v D2O, 200 uM DSS, 0.02 % v/v sodium azide	trifluoroethanol/water	0	4.5	1 atm	298	Bruker AVANCE III HD 700
3	2D 1H-1H NOESY	1.6 mM sHVF18, 50 % v/v TFE, 10 % v/v D2O, 200 uM DSS, 0.02 % v/v sodium azide	trifluoroethanol/water	0	4.5	1 atm	298	Bruker AVANCE III HD 700
4	2D 1H-1H NOESY	1.6 mM sHVF18, 50 % v/v TFE, 10 % v/v D2O, 200 uM DSS, 0.02 % v/v sodium azide	trifluoroethanol/water	0	4.5	1 atm	298	Bruker AVANCE III HD 700
5	2D 1H-1H ROESY	1.6 mM sHVF18, 50 % v/v TFE, 10 % v/v D2O, 200 uM DSS, 0.02 % v/v sodium azide	trifluoroethanol/water	0	4.5	1 atm	298	Bruker AVANCE III HD 700
6	2D 1H-1H ROESY	1.6 mM sHVF18, 50 % v/v TFE, 10 % v/v D2O, 200 uM DSS, 0.02 % v/v sodium azide	trifluoroethanol/water	0	4.5	1 atm	298	Bruker AVANCE III HD 700
7	2D DQF-COSY	1.6 mM sHVF18, 50 % v/v TFE, 10 % v/v D2O, 200 uM DSS, 0.02 % v/v sodium azide	trifluoroethanol/water	0	4.5	1 atm	298	Bruker AVANCE III HD 700
8	2D 1H-13C HSQC aliphatic	1.6 mM sHVF18, 50 % v/v TFE, 10 % v/v D2O, 200 uM DSS, 0.02 % v/v sodium azide	trifluoroethanol/water	0	4.5	1 atm	298	Bruker AVANCE III HD 700
9	2D 1H-15N SOFAST-HMQC	1.6 mM sHVF18, 50 % v/v TFE, 10 % v/v D2O, 200 uM DSS, 0.02 % v/v sodium azide	trifluoroethanol/water	0	4.5	1 atm	298	Bruker AVANCE III HD 700
10	2D 1H-13C HSQC-TOCSY	1.6 mM sHVF18, 50 % v/v TFE, 10 % v/v D2O, 200 uM DSS, 0.02 % v/v sodium azide	trifluoroethanol/water	0	4.5	1 atm	298	Bruker AVANCE III HD 700
11	2D 1H-13C HMBC	1.6 mM sHVF18, 50 % v/v TFE, 10 % v/v D2O, 200 uM DSS, 0.02 % v/v sodium azide	trifluoroethanol/water	0	4.5	1 atm	298	Bruker AVANCE III HD 700

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III HD	700

NMR Refinement
Method	Details	Software
molecular dynamics		GROMACS

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	60
Conformers Submitted Total Number	10
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
2	chemical shift assignment	CcpNmr Analysis		CCPN
3	structure calculation	GROMACS		M.J. Abraham, T. Murtola, R. Schulz, S. Pall, J.C. Smith, B. Hess, E. Lindahl

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.